Novo Nordisk, Anthropic Partner to Use Claude in Drug Discovery Workflows

The tie-up is less about a model doing science than about where AI vendors are finding durable enterprise demand: regulated, data-rich incumbents rather than crypto-native users. Novo Nordisk gains a general-purpose assistant woven into existing R&D, while Anthropic gains a marquee pharma reference in a sector where validation and audit trails matter more than benchmark scores. Whether such deployments move from workflow assistance to anything closer to discovery is the open question, and no financial terms means the commercial weight stays unclear.